Table 1.
Author [reference], year | Number of cases | Type of infection | Corynebacterium species | Previous therapies | Dalbavancin indication | Dalbavancin dose regimen | Adverse effects | Outcome |
---|---|---|---|---|---|---|---|---|
Molina-Collada [6], 2017 | n=1 | Septic native knee arthritis | C. striatum | Linezolid Teicoplanin |
Failure (n=1) | 1500 mg (one dose) | None (n=1) | Cure (n=1) |
Navarro-Jiménez [7], 2022 | n=7 | Diabetic foot osteomyelitis | C. striatum | Cotrimoxazole, tedizolid, ciprofloxacin, linezolid, amoxicillin-clavulanate, clindamycin | Failure (n=3) Side effects (n=3) Failure and Side effects (n=1) |
1500 mg (one dose) to 1500 mg weekly for 5 weeks | None (n=5) Nausea (n=1) |
Cure (n=6) Failure (n=1) |
Mansoor [8], 2023 | n=6 | LVAD | C. striatum | Vancomycin, tedizolid, daptomycin, levofloxacin, omadacycline | Convenience (n=5) Side effects (n=1) |
1500 mg every two weeks | None (n=6) | Cure (n=3) Heart transplantation (n=1) Failure (n=1) LVAD thrombosis (n=1) |
Soderqüist [9],2023 | n=1 | PJI | C. striatum | Vancomycin, linezolid, daptomycin | Side effects (n=1) | 1500 mg every week for 12 weeks | None (n=1) | Cure (n=1) |
Camara [present case], 2023 | n=1 | PJI | C. striatum | vancomycin | Convenience (n=1) | 1000 mg (load dose) and 500 mg weekly for 6 weeks. | None (n=1) | Cure (n=1) |
LVAD: Left Ventricular Assist Device; PJI: Periprosthetic joint infection.